Pharmaceutical composition for treating postpartum neurosis intestinal obstruction

Abstract

The invention discloses a pharmaceutical composition for treating postpartum neurosis intestinal obstruction in order to solve the treatment problem of the postpartum neurosis intestinal obstruction. The pharmaceutical composition is characterized by comprising raw materials including, by weight, aspongopus chinensis dallas, alyxia, timonius arboreus, scandent schefflera root, wikstroemia micrantha hemsl, allium victorialis L, mulberries, ranunculus ternatus thumb, Chinese starjasmine stem, amblystegium serpens, cinnamomum cassia presl and setaria italica beauv. Clinical trials prove that the pharmaceutical composition has the advantages of good curative effect on postpartum neurosis intestinal obstruction, high security, and being worthy of clinical application and promotion.

Description

technical field

[0001] The invention relates to the field of traditional Chinese medicine, in particular to a pharmaceutical composition for treating postpartum neurological intestinal obstruction. Background technique

[0002] Neurosis Intestinal Obstruction (NIO) is divided into paralytic neuropathic ileus and spastic neuropathic ileus according to symptoms, and its pathogenesis is mostly caused by abdominal stimulation. Whether it is natural childbirth or caesarean section, it is a huge change in the state of the abdominal cavity, making it the initiating factor of NIO, followed by intestinal muscle motility disorders.

[0003] Postpartum NIO differs from the common postoperative paralytic ileus. One is that this lesion can occur after any mode of delivery and is clearly related to the patient's constitution. The root cause of its occurrence is the patient's high sensitivity to changes in the abdominal cavity environment. The second is that postpartum NIO manifests as a...